CA
NZ
UK
AU
IND
US
Cellectar Biosciences, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting condensed consolidated financial statements and related disclosures.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,930,133 shares of Cullen/Frost Bankers Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 1,717,200 shares of common stock in Contango Silver & Gold Inc., representing 5.1% of the class, as of the triggering event date of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 7,737,938 shares of Compass Therapeutics Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,331,535 shares of Corvus Pharmaceuticals Inc. common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 4,994,047 shares of CRISPR Therapeutics AG common stock as of September 30, 2026.
Vista Energy, S.A.B. de C.V. filed a Form 6-K on November 10, 2026, disclosing a repurchase of 30,000 Series A shares conducted on November 9, 2026, at a price of Mexican Pesos 1,064.26 per share.
● Take-Two reiterated fiscal 2027 net bookings of $8 billion to $8.2 billion.
● Anthropic's IPO filing cites roughly $895 billion in AI commitments through 2045.
● The cluster lands just ahead of Nvidia's November 17 report.
Please wait processing your request...